Treatment for osteoporosis does not appear to increase AF risk

A variety of pharmacotherapy options are available for the management of osteoporosis, but concern has arisen about the inconclusive nature of information about the potential association of these treatments with cardiovascular events, particularly atrial fibrillation...

Warfarin vs NOACs for AF – dead men (and women) do tell tales …

German researchers have recently compared real-world effectiveness and safety of non-vitamin-K-antagonist oral anticoagulant (NOAC) treatment for patients with atrial fibrillation (AF) against warfarin. This retrospective analysis examined defintive outcomes including...

Antidepressants and QT prolongation

A very thorough review of the effects of antidepressant treatment upon the QT interval is an excellent resource for clinicians dealing with this matter in the care of older people. TCAs and citalopram are associated with the greatest risk for QT prolongation in older...

Lithium does not sustain ketamine induced antidepressant effects

There has been a lot of hype about the use of ketamine to produce a rapid antidepressant effect, but the fact remains that the effect is arher short-lived. Recent research was conducted to assess if lithium was more effective than placebo as a continuation strategy...